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ABSTRACT
To establish infection, a retrovirus must insert a DNA
copy of its RNA genome into host chromatin. This re-
action is catalysed by the virally encoded enzyme in-
tegrase (IN) and is facilitated by viral genus-specific
host factors. Herein, cellular serine/threonine pro-
tein phosphatase 2A (PP2A) is identified as a func-
tional IN binding partner exclusive to -retroviruses,
including human T cell lymphotropic virus type 1 and
2 (HTLV-1 and HTLV-2) and bovine leukaemia virus
(BLV). PP2A is a heterotrimer composed of a scaf-
fold, catalytic and one of any of four families of reg-
ulatory subunits, and the interaction is specific to
the B′ family of the regulatory subunits. B′-PP2A and
HTLV-1 IN display nuclear co-localization, and the B′
subunit stimulates concerted strand transfer activity
of -retroviral INs in vitro. The protein–protein inter-
action interface maps to a patch of highly conserved
residues on B′, which when mutated render B′ inca-
pable of binding to and stimulating HTLV-1 and -2 IN
strand transfer activity.
INTRODUCTION
Of the seven retroviral genera (lenti-, -, -, −, -,
- and spumavirinae), two are known to cause severe
and fatal conditions in humans. The lentiviruses human
immunodeficiency virus type 1 (HIV-1) and HIV-2 are
the aetiological agents of acquired immunodeficiency syn-
drome. The -retrovirus human T-cell lymphotropic virus
type 1 (HTLV-1) causes adult T cell leukaemia-lymphoma
(ATL) and the neurological disorder HTLV-1 associated
myelopathy/tropic spastic paraparesis (HAM/TSP). A
range of inflammatory diseases, such as uveitis, infective
dermatitis, arthritis and others is also caused byHTLV-1 in-
fection.Approximately 5%ofHTLV-1 infected people even-
tually develop ATL, of whom most die within two years of
symptom presentation (1). The treatment of both the in-
flammatory and malignant conditions remains unsatisfac-
tory.
To establish infection, a retrovirus must insert a DNA
copy of its RNA genome into host cell DNA. The key steps
of this process are catalysed by the retroviral enzyme inte-
grase (IN). Following reverse transcription, IN recognizes
and binds to the viral long terminal repeat (LTR) ends of the
viral DNA in a sequence specific manner to form the pre-
integration complex (PIC) (2). Within the PIC, IN cleaves
the 3′ ends of the viral DNA adjacent to invariant CA din-
ucleotides. This step, known as the 3′ processing reaction,
produces 3′-OH groups that are used as nucleophiles during
strand transfer. Following engagement with host DNA into
a target capture complex, the 3′-OH groups attack scissile
phosphodiester bonds on opposing strands within the tar-
get DNA, splicing the viral and cellular genomes together.
The resulting single strand gaps in the integration interme-
diate are repaired by cellular machinery to yield the inte-
grated provirus flanked by a short duplication of hostDNA,
which is 6 bp for the -retroviruses (3,4). Whilst the inter-
action between IN and viral LTR ends is DNA sequence-
specific (5), the engagement of host DNA is much less so
(6). Alignments of experimentally determined integration
sites uncovered weakly conserved palindromic DNA con-
sensus sequences (3,6–10). On the genomic level, integra-
tion site selection is determined by the interaction between
IN and genus-specific host factors. Indeed, INs fromHIV-1
and other lentiviruses bind LEDGF/p75, a transcriptional
co-activator that targets PICs to actively transcribed genes
(11–13), whilst  -retroviral INs usurp a family of bromod-
omain containing proteins to home in on transcription start
sites (14–16).
Recent high-throughput genome-wide sequencing of
HTLV-1 integration sites from HAM/TSP patients com-
bined with in vitro generated integration sites revealed a
strong bias for integration into active regions of the genome
(3). In a subset of the analysed integration sites, there ap-
peared to be a strong preference for integration within
close proximity of certain transcription factor binding sites
(TFBS) (17), a trait that is shared by HTLV-2 (4). The
strongest integration site preference was observed near p53,
STAT1 and HDAC6 TFBS (17). Based on these obser-
vations, it seems unlikely that -retroviral PICs associate
with a single transcription factor/chromatin binding pro-
tein, but rather might be targeted to the site of integra-
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tion by a protein that associates with different transcription
factors/chromatin binding proteins.
Herein, proteomic analyses identified a heterotrimeric
serine/threonine protein phosphatase PP2A as a binding
partner of -retroviral IN proteins. PP2A is a ubiquitously
expressed protein involved in a myriad of cellular processes
(18). PP2A is active as a heterotrimer; the core dimer com-
posed of the catalytic C subunit and the scaffold subunit A
is joined by one of four different regulatory subunit fam-
ilies: B, B′, B′′ or B′′′ to form the heterotrimer. Two highly
conserved isoforms ( and) exist for both the catalytic and
the scaffold subunit. The B′ family is the largest, counting
at least five members (, ,  ,  and ) of which  and 
express at least three isoforms, and  has an additional al-
ternative translation isoform. Formation of the holoenzyme
regulates subcellular localization of PP2A, substrate speci-
ficity but also stability of the PP2A components (19).
Here, I show that the PP2A comprising the B′ regula-
tory subunits (hereafter referred to as B′-PP2A) associate
specifically and exclusively with INs from the -retroviral
genus, and the B′ subunits stimulate biologically-relevant
concerted integration activity of HTLV-1 and -2 INs. Map-
ping of the interaction binding site on B′ illustrates that
residues critical for binding to and stimulating HTLV-1 and
-2 IN are highly conserved.
MATERIALS AND METHODS
A detailed description of the generation of the DNA con-
structs and the Methods describing the purification of all
recombinant proteins used in this manuscript, the stable
HEK293T-derived cell lines generated and conditions for
immunoprecipitation and nickel-nitrilotriacetic acid (Ni-
NTA) pull-downs can be found in the Supplementary Data.
Strand transfer assays
Short double stranded donor DNAs that mimic the U5
end of the HTLV-1 or HTLV-2 LTR were made by an-
nealing oligonucleotides shown in Supplementary Table S1.
For HTLV-1, blunt DNA substrate was made by annealing
S20B with S20UN, whilst donor DNA mimicking 3′ pro-
cessed LTR ends was made by annealing S20B with S20UP
(20). For HTLV-2 IN substrate DNA of different lengths
were used; donor DNA of 24 nucleotides mimicking pre-
processed DNA was made by annealing S24UP with S24B
whilst blunt DNA substrate was produced by annealing
S24B with S24UN. Similarly, donor DNA counting 19 or
30 base pairs were made by annealing S19B with S19UP (3′
processed mimic) or S19UN (blunt) and S30B with S30UP
(3′ processed mimic) or S30UN (blunt). Strand transfer
reactions contained 0–4 M B′ (11–380), 2.8 M donor
DNA, 50 mM NaCl, 10 mM MgCl2, 13 mM DTT, 5.8
M ZnCl2, 0.132 M HEPES pH 7.1 and 300 ng pGEM-
9Zf(-) in a total volume of 30 l and were started by ad-
dition of IN to a final concentration of 1 M to 6 M.
B′ (11–380) was used at different concentrations as indi-
cated in the figures. Reactions, which spanned 60 or 90 min
as indicated in figure legends, were stopped by addition of
0.5% SDS/25 mM EDTA, pH 8.0. Proteins were degraded
by incubation with 30 g proteinase K at 37◦C for 1 h.
DNAproducts, concentrated by ethanol precipitation, were
separated by electrophoresis through 1.5% agarose and de-
tected by staining with GelRed (VWR). To quantify strand
transfer by PCR, donor DNA S20PQ (made by annealing
S20UPQ with S20BQ) for HTLV-1 and S24PQ (by anneal-
ing S24UPQwith S24BQ) for HTLV-2 INwere used. Quan-
tification was done as described previously (21). Standard
curves were made by serial dilution of a reaction supple-
mented with wild type B′ (11–380). Concerted integration
products were isolated and cloned for sequencing as de-
scribed previously (6,22,23).
RESULTS
Identification of -retroviral IN specific binding partners
To identify specific binding partners of -retroviral INs,
proteins co-purifying with HTLV-1 or BLV IN (bovine
leukaemia virus integrase) from extracts of HEK293T cells
stably expressing C-terminally Flag-tagged versions of the
viral proteins were analysed by tandem mass spectrome-
try. Several transcription factors, chromatin remodellers,
enzymes involved in DNA damage repair as well as sub-
units of the cohesin and condensin complexes were iso-
lated in these experiments (Supplementary Tables S2 and
S3). Strikingly, subunits of the heterotrimeric phosphatase
PP2A co-purified with BLV IN in close to stoichiometric
quantities (Figure 1) including ,  ,  and  isoforms of
its B′ regulatory subunit (Supplementary Table S2). Pep-
tides corresponding to the scaffold and B′ regulatory sub-
units were also highly enriched with HTLV-1 IN (Figure 1,
Supplementary Table S3). Absence of the brain-specific 
isoform of B′ was not unexpected (24,25). In contrast to
B′ isoforms, no peptides derived from the B and B′′ reg-
ulatory PP2A subunits were found in the immunoprecip-
itates. Western blotting confirmed enrichment of the cat-
alytic, scaffold and B′ subunits, and the absence of a B-type
regulatory subunit in HTLV-1 IN-Flag immunoprecipita-
tions (IPs) (Figure 2A). Although 4 peptides were identified
from STRIATIN 4 (a B′′′ type of regulatory subunit, Sup-
plementary Table S3), interaction between BLV or HTLV-1
IN and STRIATIN 4 could not be confirmed by indepen-
dent Flag-IPs (Figure 2A). The HTLV-1 IN-B′ interaction
resisted challenge with NaCl concentrations up to at least
450 mM (Supplementary Figure S1).
To investigate whether PP2A is a binding partner of
retroviral INs in general, or specifically associates with -
retroviral INs, IPs were done with extracts from cells that
stably express C-terminally Flag-tagged versions of HIV-
1 (lentivirus), feline leukaemia virus (FeLV,  -retrovirus),
murine leukaemia virus (MLV,  -retrovirus), prototype
foamy virus (PFV, spumaretrovirus), Mason Pfizer mon-
key virus (MPMV, -retrovirus), BLV and HTLV-1 IN
(-retrovirus) versus the parental HEK293T cell line. B′-
PP2A co-purified specifically and exclusively with IN pro-
teins from the -retroviral genus (Figure 2B). Immunos-
taining of transiently expressed B′ (11–380) fused to en-
hanced green fluorescent protein (EGFP-B′ (11–380)) and
Flag-tagged IN in HeLa cells showed that B′ (11–380) co-
localizes with HTLV-1 IN in the nucleus (Supplementary
Figure S2). Although PFV IN was also nuclear, it dis-
played a more punctate distribution pattern clearly distinct
 at Im
perial College London on January 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
366 Nucleic Acids Research, 2016, Vol. 44, No. 1
Figure 1. PP2A co-precipitates with BLV and HTLV-1 IN. Colloidal coomassie stained gels of the large scale Flag-IPs done with BLV IN (A) and HTLV-1
IN (B). Bands from the IN and the negative control lanes (indicated with arrows and arrow heads) were excised and analysed in parallel. Migration of the
PP2A components is indicated to the right of the gel. Migration of the protein standard (Mark 12, Life Technologies) in kDa is indicated to the left of the
gels.
Figure 2. The interaction between PP2Aand IN is genus-specific. (A) Flag-
IP of transiently expressed Flag-tagged BLV andHTLV-1 IN inHEK293T
cells. This is not a composite image; the vertical line was added to delin-
eate the border between input and IP samples. *Degradation product of
C. (B) Flag-IP using INs from different retroviral genera stably expressed
in HEK293T cells. As a negative control, the parental cell line was used.
Retroviral genus is indicated above the blot. Antibodies used are indicated
to the right of the blot. **Degradation product of PFV IN.
from that of B′ (11–380) (Supplementary Figure S2). Since
monomeric B′ subunits are degraded rapidly in cells, local-
ization of B′ subunits reflects the intracellular distribution
of B′ containing PP2A holoenzymes (26), suggesting that
HTLV-1 IN co-localizes with B′-PP2A.
PP2A associates with -retroviral IN directly through the B′
regulatory subunit
Since only members of the B′ family and none from the
other families of regulatory subunits specifically co-purified
with both the HTLV-1 and BLV IN Flag-IPs, the regula-
tory subunit likely mediates the interaction. Given the lack
of sequence homology with HEAT (huntingtin-elongation
A-subunit-TOR) repeat proteins, the B′ proteins are re-
ferred to as pseudo-HEAT repeat proteins (27–29), in which
pseudo-HEAT repeats (composed of two anti-parallel -
helices connected by intra-loops) are arranged in tandem
and linked by short inter-unit loops. The B′ pseudo-HEAT
repeats compose a highly conserved central region (with
∼80% amino acid sequence identity) (Supplementary Fig-
ure S3), whilst the distinct N-terminal and C-terminal ex-
tensions are thought to contribute to substrate specificity.
The conserved central region of three B′ isoforms ( , , ),
one full-length B′′ regulatory subunit, and the  isoform of
the scaffold subunit Awere cloned, expressed and purified
from bacteria. Ni-NTA pull down assays were performed
using hexa-histidine-tagged INproteins. Since only very low
yields of soluble recombinant full-length BLV IN were re-
covered from bacteria, the -retroviral INs from HTLV-1
and HTLV-2 were used in these experiments; the lentiviral
HIV-1 and feline immunodeficiency virus (FIV) INs served
as negative controls. B′ (11–380) (Figure 3A) and B′(76–
501) (Figure 3B) interacted with HTLV-1 and HTLV-2 IN,
but not with the lentiviral INs. Moreover, only the B′ iso-
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Figure 3. HTLV-1 IN binds directly to the B′ regulatory subunit. (A) NiNTA pull-downs using hexahistidine tagged HTLV-1 and -2 or FIV IN as bait.
Five micrograms of bait and B′ (11–380) were used. Input and pull-down samples are indicated above the gel. (B) B′(76–501) binds to HTLV-1 IN but
not to HIV-1 IN. NiNTA pull-downs as described in (A). Migration of B′(76–501) and the IN proteins is indicated to the right of the gel. Lane 1: input
of B′(76–501), lane 2: pull-down using HIV-1 IN-His6 as bait, lane 3: pull-down using HTLV-1 IN-His6 as bait. (C) NiNTA pull-down with either no IN
(negative control) or HTLV-1 IN-His6 as bait. Addition of B′′, or B′ (11–380) to the pull-downs is indicated above the gel. The input of B′′ was originally
loaded on a different gel; the vertical line illustrates the border between the two gels. (D) Three isoforms of B′: B′ (11–380), B′(76–501) and B′(51–401),
and the scaffold subunit A were tested for binding to HTLV-1 and HTLV-2 IN-His6 by NiNTA pull-down. No IN was added in the negative control
samples. The input of A was originally loaded on a different gel; the vertical line illustrates the border between the two gels. Input and pull-down are
indicated above the gel. Migration of the proteins is indicated to the right of the gels. Migration of the molecular weight marker (in kDa) is indicated to
the left of the gel. All gels were stained with Coomassie.
forms directly associated with HTLV-1 and HTLV-2 IN,
as direct association between HTLV-1 IN and B′′ was not
observed (Figure 3C and D). B′(51–401) interacted with
HTLV-1 and -2 IN, whilst the structural subunit, A, ap-
peared to non-specifically precipitate on the Ni-NTA beads
(Figure 3D).
B′ stimulates concerted strand transfer activity of -retroviral
INs
In vitro activities of HTLV-1 and HTLV-2 IN were previ-
ously characterised using radio-actively labelled oligonu-
cleotides that mimicked the respective LTRs. Balakrishnan
and Jonsson showed that the catalytic activity of HTLV-1
and -2 IN was highly sensitive to NaCl, and 3′-processing
and strand transfer activities were inhibited by concentra-
tions exceeding 100 mM (20,30). All our reactions were
done in the presence of 50 mM NaCl. To distinguish half-
site integration from the biologically relevant concerted in-
tegration activity, the previously reported assay was used
in which short viral LTR mimics function as donor DNA
and supercoiled plasmid (pGEM) as target DNA (6,22,23).
Concerted integration hence results in linearisation of the
plasmid, whilst half-site integration co-migrates with open
circular plasmid DNA (Figure 4A). Some concerted strand
transfer activity was observed in the presence of 6 M
HTLV-1 IN (Figure 4B lane 7), and when using 4 M
HTLV-1 IN the activity was considerably increased in the
presence of as little as 0.25 M B′ (11–380) (Figure 4B
compare lanes 6 and 13). Similarly, the biologically-relevant
activity of HTLV-2 IN was significantly increased in the
presence of B′. The effect of B′ (11–380) addition to the
reaction was dose-dependent (Figures 4B and C) and con-
certed integration or nicking activity was not observed
when B′ (11–380) was added alone (Figure 4B lane 11).
Whilst maximum stimulation of concerted integration ac-
tivity was observed using a ∼4:1 molar ratio of HTLV-1 IN
: B′ , and 2:1 molar ratio for HTLV-2 IN : B′ , a signifi-
cant stimulation could be observed at ratios of HTLV IN
: B′ of 16:1 (Figure 4B lane 13 and Figures 4D and 4E).
The ∼150-fold greater stimulation of concerted integration
activity of HTLV-2 IN by B′ compared to HTLV-1 IN is
due to the fact that ∼150-fold less products of integration
are detected when HTLV-2 IN is used on its own. Of impor-
 at Im
perial College London on January 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
368 Nucleic Acids Research, 2016, Vol. 44, No. 1
Figure 4. B′ stimulates -retroviral strand transfer activity of HTLV-1 and -2 IN. (A) Scheme explaining concerted versus half-site integration (23).
Whereas insertion of one donor DNA substrate into the supercoiled plasmid DNA results in an open circular form of DNA (half-site integration) (left),
concerted integration of two donor DNAmolecules results in a linear strand transfer product (right). (B) and (C) Donor DNAmimicking the 3′-processed
ends was used (S20P for HTLV-1 IN and S30P for HTLV-2 IN). Presence of donor DNA, B′ (11–380), HTLV-1 IN (B) or HTLV-2 IN (C) and tDNA
(pGEM9zf(-)) are indicated above the gel. (B) Integration assays with HTLV-1 IN. Concentration of proteins used: in the absence of B′ (11–380): lanes
1, 2, 8, 9 and 12: 4 M IN; lanes 3 and 10: no IN; lane 4: 1 M IN; lane 5: 2 M IN; lane 6: 4 M IN; lane 7: 6 M IN. Lanes 12–16 were done in the
presence of 4 M IN with the following concentration of B′ (11–380): lane 12: 0 M B′; lane 13: 0.25 M B′; lane 14: 0.5 M; lane 15: 1 M, lane 16: 2
M. Lane 11 was done in the absence of IN and presence of 2 M B′ (11–380). (C) Integration assays with HTLV-2 IN. In the absence of B′ (11–380):
lanes 1 and 2: 4 MIN; lane 3: no IN; lane 4: 1 MIN; lane 5: 2 MIN; lane 6: 4 MIN. Lanes 7–10 were done using 1 MHTLV-2 IN and the following
concentrations of B′ (11–380): lane 7: 0.25 M; lane 8: 0.5 M; lane 9: 1 M and lane 10: 2 M. DNA products were separated on a 1.5% agarose gel
and stained with GelRed. Migration of DNA species in the gel is indicated on the right of the gel. S.c., supercoiled; o.c., open circular. The 1 kb DNA
ladder (NEB, indicated on the left of the gel) was used as a reference. This is a representative of experiments repeated four times (HTLV-1 IN) and three
times (HTLV-2 IN). For quantification, S20PQ (HTLV-1 IN) (D) and S24PQ (HTLV-2 IN) (E) were used as donor DNA. Strand transfer activity was
quantified as published earlier (21). A standard curve was made using reactions done with HTLV IN: B′ in a 2:1 molar ratio and strand transfer products
were quantified in relation to this standard curve. Fold stimulation of integration activity was determined by calculating the increase in product compared
to the reactions done in the absence of B′ . Bar plots were made by calculating the averages and standard deviations of three independent experiments.
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tance, in these reactions 1MHTLV-2 IN is used compared
to 4 M HTLV-1 IN. However, repeating the experiments
with 1 MHTLV-1 IN still produces ∼78 times more inte-
gration product than HTLV-2 IN (data not shown). It thus
appears that HTLV-1 IN is more active than HTLV-2 IN
and HTLV-2 IN is more dependent on B′ than HTLV-1
IN under the conditions described here.
In the reactions described above, the substrates mimicked
3′ processed LTRs. When using blunt DNA substrates that
represent the unprocessed LTRs and using HTLV-1 or -2
IN in the presence of B′ using a 2:1 molar ratio, HTLV-
1 IN appeared equally active for supporting concerted viral
DNA integration (Figure 5A, compare lanes 4 and 5), whilst
HTLV-2 IN was significantly more active on processed sub-
strates (Figure 5B, compare lanes 4 and 5, 6 and 7, 8 and 9).
Although four times as much HTLV-1 IN as HTLV-2 IN
was used in these assays, the same was observed when using
equivalent concentrations of HTLV-2 IN (Supplementary
Figure S4, compare lanes 4 and 5). This suggests that for-
mation of the active presynaptic complex is more efficient
with HTLV-1 IN than with HTLV-2 IN.
Retroviral INs integrate the viral cDNA across the major
groove of tDNA, attacking scissile phosphodiester bonds of
opposing strands in a staggered fashion leading to a short
duplication of the integration site sequence. Since no de-
tectable (HTLV-2 IN) or very low levels (HTLV-1 IN) of
concerted integration products are produced in the absence
of the PP2A regulatory subunit, strand transfer products
made in the presence of B′ were cloned and sequenced
as described previously (6,22,23). For HTLV-1, 41 (93%)
of the cloned integration products had the expected 6-bp
duplication, 2 clones a 7-bp (5%) and 1 clone had a 4-bp
duplication (2%). Thirty one (82%) of the HTLV-2 IN con-
certed integration products had a 6-bp duplication, 1 clone
(3%), a 5-bp duplication and 6 clones (16%), a deletion or
rearrangement (Figure 5C). The small percentage of clones
with deletions or rearrangements could possibly have arisen
from the cloning or selection procedures used. Overall, the
large majority of the HTLV-1 and -2 concerted integration
products are legitimate. To investigate whether HTLV-1 or
-2 IN influence the enzymatic activity of PP2A, Flag-tagged
B′ -PP2A holoenzymes were isolated from HEK293T cells
(Supplementary Figure S5A and B) and phosphatase ac-
tivity was measured using the phospho-Thr PP2A specific
peptide (R-K-pT-I-R-R) (31). Only when 5-fold molar ex-
cess of HTLV-1 or -2 IN was added to the reactions was
the Flag-tagged B′ -PP2A activity reduced with ∼25–30%
(Supplementary Figure S5C).
Mapping of the interaction on B′
To further map the interaction of IN binding to B′ , a set
of deletion mutants in which pseudo-HEAT repeats were
removed from the N- or C-terminal end were designed,
expressed and purified from bacteria (Figure 6A and B).
B′ fragments separated between pseudo-HEAT repeats 3
and 4 displayed reduced binding to HTLV-1 IN (Figure
6C). Following this serendipitous observation, a set of B′
mutants, expressed in HEK293T cells in HA-tagged form
were tested for their ability to co-IP with HTLV-1 IN-Flag.
Since -retroviral INs interact with the B′ PP2A holoen-
zyme (Figures 1 and 2A), only exposed residues surround-
ing pseudo-HEAT repeats 3 and 4 not involved in binding to
the structural or catalytic subunit were chosen for mutage-
nesis (Figure 6B). B′ (11–380)mutant 5, in which Arg188,
Leu194 and Arg197 were mutated to Ala was unable to co-
IP with Flag-tagged HTLV-1 IN (Figure 7A). To identify
the residues critical for the interaction single point mutants,
B′ (11–380)mutant 7 (R188A), mutant 8 (L194A) and mu-
tant 9 (R197A) were produced (Figure 6B). In addition,
given the close proximity of the loop connecting pseudo-
HEAT repeats 4 and 5, residues Leu237 and Pro238 were
mutated to Ala in mutant 10 (Figure 6B). Whilst R188 does
not appear to be involved in binding to HTLV-1 IN, L194
andmore significantly R197 were critical for the interaction
(Figure 7A). Mutant 10 was also unable to co-precipitate
with Flag-tagged HTLV-1 IN (Figure 7A), whilst individ-
ually mutating residues L237 and P238 only partially re-
duced binding to HTLV-1 IN (data not shown). Interest-
ingly, the scaffold subunit A co-precipitated with Flag-
tagged HTLV-1 IN in extracts made from cells expressing
mutant B′ proteins incapable of binding to HTLV-1 IN.
This is most likely due to the interaction of HTLV-1 IN
with endogenous B′ isoforms. Indeed, endogenous B′ co-
precipitated with Flag-tagged HTLV-1 IN irrespective of
which B′ mutant was expressed (Figure 7A). Of impor-
tance, none of themutations introduced into the B′ protein
affected its binding to the scaffold and catalytic subunits
(Supplementary Figure S6) illustrating that these mutations
do not alter the overall structure of the B′ proteins. This
further corroborates the observation that residues L194,
R197, L237 and P238 are involved in direct interaction with
HTLV-1 IN.
To further investigate the importance of these interac-
tions, mutants 5, 8, 9 and 10 were cloned, expressed and
purified from bacteria and their binding to HTLV-1 and
HTLV-2 IN was investigated using Ni-NTA pull-downs. As
expected, mutants 5 and 9 were unable to associate with
HTLV-1 and HTLV-2 IN-His6, whilst mutant 8 and 10 re-
tained some residual binding to HTLV-1 and -2 IN (Figure
7B).
As expected, mutants 5 and 9 failed to stimulate con-
certed integration of HTLV-1 and -2 IN. In agreement with
the observed reduction in binding affinity for HTLV-1 and
-2 IN, point mutants 8 and 10 were also significantly (5-
to 10-fold) less able to stimulate strand transfer activity
of these -retroviral INs (Figure 7C–E). Of interest, B′
residues L194, R197, L237 and P238 point away from the
described PP2A substrate binding site (Figure 8A) and are
conserved in all five human and bovine B′ isoforms (Fig-
ure 8B and Supplementary Figures S3 and S7), explaining
the present interaction between bovine IN and human B′-
PP2A (Figure 1 and Supplementary Table S2). Moreover,
except for B′ (L194) which is a Met in Arabidopsis thaliana
B′, R197, L237 and P238 are conserved in Saccharomyces
cerevisiae, Schizosaccharomyces pombe, Caenorhabditis ele-
gans, Drosophila melanogaster and Arabidopsis thaliana B′
homologues (29) (Figure 8B).
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Figure 5. HTLV-1 and -2 IN are active on blunt substrates. Integration reactions done with HTLV-1 or HTLV-2 IN using either blunt (B) or pre-processed
(P) donor DNA as substrate. Reactions were allowed to take place at 37◦C for 90 min before the reactions were stopped. (A) Reactions done with HTLV-1
IN. All reactions (except for lane 3 where IN was omitted) contained 4 MHTLV-1 IN and 2 MB′ (11–380). Lane 1: no donor, lane 2: no tDNA; lane
3: no IN; lane 4: blunt donor; lane 5: pre-processed donor. (B) Reactions with HTLV-2 IN. Donor DNA of different lengths were used as indicated above
the gel. All reactions (except for lane 3 where IN was omitted) contained 1 MHTLV-2 IN and 0.5 MB′ (11–380). Lane 1: no donor, lane 2: no tDNA;
lane 3: no IN; lane 4: blunt donor DNA 19-mer; lane 5: pre-processed 19-mer; lane 6: blunt 24-mer; lane 7: pre-processed 24-mer; lane 8: blunt 30-mer
and lane 9: pre-processed 30-mer. DNA products were separated on a 1.5% agarose gel and stained with GelRed. Migration of DNA species in the gel is
indicated on the right of the gel. S.c. supercoiled; o.c., open circular. The 1 kb DNA ladder (NEB, indicated on the left of the gel) was used as a reference.
Gels representative of three independent experiments are shown. (C) Products of concerted integration catalysed by HTLV-1 or -2 IN in the presence of B′
(2:1 molar ratio) were cloned and sequenced. Percentage of 6 bp duplication, other duplications and deletions are shown in pie charts. Fourty four clones
were sequenced for HTLV-1 IN and 38 for HTLV-2 IN.
DISCUSSION
BLV and HTLV-1 IN bind specifically to the B′ PP2A
holoenzyme. Whilst numerous peptides were identified for
the scaffold and B′ regulatory subunits only few (BLV IN)
or none (HTLV-1 IN) were identified for the catalytic sub-
unit. This is most likely due to the fact that the catalytic
subunit co-migrates with BLV and HTLV-1 IN in SDS-
PAGE gels and the bands corresponding to the IN proteins
were not analysed by tandemmass spectrometry. Neverthe-
less, independent Flag-IPs followed by western blot detec-
tion illustrates that both delta-retroviral INs specifically co-
precipitate the PP2A holoenzyme containing B′ regulatory
subunit (Figure 2A). PP2A is an essential and ubiquitous
protein phosphatase that can make up 0.1–1% of the to-
tal cellular protein (32). A highly versatile enzyme, it plays
critical functions in cellular homeostasis by being involved
in a wide range of processes including DNA damage re-
sponse, cell signalling, chromosome segregation, and apop-
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Figure 6. (A) Cartoon representation created in Pymol of B′1 (PDB 2IAE) (27) showing the pseudo-HEAT repeats in different colours, and labelled
above the repeats as HEAT 1–8. The brackets on top of the cartoon refer to the deletion mutants designed to express HEAT repeats 1–3 (B′ (11–194))
and 4–8 (B′ (195–380). (B) Schematic representation of the pseudo-HEAT repeats in B′ . The deletion mutants and point mutants used in this work are
drawn underneath the full length (FL) protein. Start and end residues of the deletion fragments are indicated. Residue(s) indicated in red, blue and black
are respectively critical, important and not involved in the interaction with HTLV-1 and -2 IN. (C) Ni-NTA pull-down done as described in Figure 3.
Binding of B′ (11–380), B′ (11–194) and B′ (195–380) to HTLV-1 IN-His6 was tested. Input and pull-downs are indicated above the gels. Migration of
B′ deletion fragments and HTLV-1 IN-His6 is indicated to the right of the gel. Migration of the molecular weight marker (in kDa) is indicated to the left
of the gel. All gels were stained with Coomassie.
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Figure 7. B′ R197, L237 and P238 are critical for the interaction with HTLV-1 IN. (A) Flag-IPs with HTLV-1 IN-Flag and HA-tagged B′ (11–380) wild
type and point mutants as indicated above the gel. Antibodies used are indicated to the right of the blots. This is not a composite figure; the vertical line was
added as a border between input and IP samples. (B) Coomassie stained gel of Ni-NTA pull-downs using HTLV-1 IN-His6 or HTLV-2 IN-His6 as bait,
with wild type and B′ (11–380) point mutants as indicated above the gel. (C–E) B′ (11–380) point mutants unable to bind to HTLV IN do not stimulate
concerted integration activity. (C) Reactions for HTLV-1 IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 20-mer).
Lane 2: no tDNA, lane 3: no IN or B′ (11–380), lane 4: no B′ (11–380). Concentrations for HTLV-1 IN and B′ (11–380) are as follows: 4 MHTLV-1
IN with either 0.25 M, 0.5 M or 1 M B′ (11–380) WT or mutants was used in the reactions as indicated above the gel. (D) Reactions for HTLV-2
IN. All lanes, except lane 1 where donor was omitted, have donor DNA (pre-processed 24-mer). Lane 2: no tDNA, lane 3: no IN or B′ (11–380). Lane
4; no B′ (11–380), lanes 4–19 1 M HTLV-2 IN. Lanes 5–7; 8–10; 11–13; 14–16; 17–19: respectively, 0.125 M, 0.25 M and 0.5 M of WT, mutant 5,
mutant 8, mutant 9 or mutant 10 B′ (11–380) as indicated above the gels. Reactions were done for 1 h at 37◦C. DNA products were separated on a 1.5%
agarose gel and stained with GelRed. The 1 kb DNA ladder (NEB, indicated to the left of the gel) was used as a reference. (C) and (D) are not composite
images; vertical lines were added in between the reactions done with different B′ mutants to simplify the image. (E) Reactions were done as described
above. Products of concerted integration were quantified as described previously (21) using the molar ratio of 2:1 IN : B′ . Donor S20PQ and S24PQ were
used for HTLV-1, respectively, HTLV-2 IN. A standard curve was made by serial dilution of the condition using WT B′ . Fold stimulation is expressed in
comparison to the reactions with WT B′ , arbitrarily set to 100%. Averages and standard deviations are shown calculated on the data obtained from three
independent experiments.
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Figure 8. B′ residues involved in binding toHTLV-1 IN are highly conserved and orient away from the substrate binding site. (A) Surface representation of
the B′-PP2A holoenzyme based on PDB: 2IAE (27). The scaffold subunit (A) is shown in orange, the catalytic subunit (C) in yellow and the B′ regulatory
subunit in brown. Residues involved in binding to HTLV-1 IN are shown as sticks and coloured as follows: carbon, green; oxygen, red; nitrogen, blue. The
active site, at the interface between B′ and C, is indicated. (B) Residues involved in binding to HTLV-1 and -2 IN (highlighted with green boxes) are
highly conserved. Alignment of HEAT repeats 4 and 5 of human B′ regulatory subunit (Hs B′ , GI: 31083259) with human B′ (Hs B′, GI: 5453950),
B′ (Hs B′, GI: 5453952), B′ (Hs B′, GI: 5453954), B′ (Hs B′, GI: 5453956), bovine B′ (Bos taurus, Bt B′ , GI: 134085946), and B′ isoforms
from Saccharomyces cerevisiae (Sc Rts1p, GI: 532526), Schizosaccharomyces pombe (Sc B′, GI: 19075706), Caenorhabditis elegans (Ce B′, GI: 17557914),
Drosophila melanogaster (Dm B′, GI: 60677747) and Arabidopsis thaliana (At B′, GI: 2244898). Numbers in brackets indicate the residue number of the
respective isoform at which the alignment starts. Numbers on top of the alignment correspond to residue numbers in the human B′ isoform. Secondary
structures indicated are based on PDB: 2IAE (27). Alignments were made in Clustal Omega (53) (http://www.ebi.ac.uk/Tools/msa/clustalo/) and the figure
was prepared using Espript 3.x (54) (http://espript.ibcp.fr/ESPript/ESPript/). For alignment with all bovine B′ regulatory subunits, see Supplementary
Figure S7.
tosis (18,19,33). The phosphatase is frequently inactivated
in acute myeloid leukaemia (34). Its activity is modulated
at multiple levels, and the specific roles of its diverse regula-
tory isoforms are only starting to emerge (35–41). Although
-retroviral INs could be a substrate of B′-PP2A, phospho-
rylated forms of HTLV-1 or BLV IN were not detected in
HEK293T cell extracts (data not shown).Moreover, recom-
binant protein used in this work was expressed and purified
from E. coli, known to lack the kinase/phosphatase system
present in eukaryotes. The direct interaction observed be-
tween recombinant B′ andHTLV-1 and -2 IN therefore sug-
gests that phosphorylation is not critical for the interaction
or the stimulation of integration activity by B′. Moreover,
mapping of the B′ residues critical for the interaction with
HTLV IN indicates that the interaction does not involve the
canonical substrate binding interface of B′-PP2A (Figure
8A).However, 3 of the 4 identified residues involved in bind-
ing to -retroviral INs are conserved in eukaryotes, from
yeast to humans (Figure 8B), suggesting that these residues
could be involved in binding to other (conserved) endoge-
nous protein(s) or substrate(s). Of importance, HTLV-1, -2
and BLV IN only share 38% sequence identity suggesting a
strong selective pressure to preserve this virus-host interac-
tion.
It is presently unclear what role B′-PP2A plays in -
retroviral infection. It is likely that binding ofHTLV-1 IN to
B′-PP2A is beneficial to the virus for more than one reason.
HTLV IN is not the first viral protein known to associate
with PP2A. Simian virus 40 small T antigen and polyoma
virus middle T antigen disrupt the PP2A holoenzyme to
replace the regulatory subunit, hereby inhibiting PP2A ac-
tivity which contributes to cellular transformation (18,19).
Also theHTLVaccessory protein Tax, a potent oncoprotein
(42), was shown to bind to PP2A and thereby stimulate cell
proliferation (43). Although Tax is only expressed in ∼40%
of the ATL cases, it is thought to contribute to the early
stages of cellular transformation (44). When investigating
the effect of HTLV-1 or -2 IN on B′-PP2A activity, a 25–
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30% reduction in B′-PP2A activity could be observed only
when the INs were present in a 5-fold molar excess to B′-
PP2A. Thus, although B′ alone is sufficient to stimulate IN
activity and IN does not influence B′-PP2A activity when
present in a 2-fold molar excess of IN to B′-PP2A, it is too
early to conclude that the functional interaction between
IN and B′-PP2A is completely independent of B′-PP2A ac-
tivity. Indeed, it is currently unknown what the local con-
centration of IN is when it meets B′-PP2A during infection.
Moreover, it is at present impossible to disregard the pos-
sibility that binding of HTLV IN, or the HTLV PIC, to B′-
PP2A influences its enzymatic activity towards, or its ability
to associate with a certain substrate(s).
It will be important to determine if the interaction be-
tween HTLV-1 IN and B′-PP2A can influence cell cycle
checkpoints and/or cellular transformation at the very early
stages of infection and whether PP2A is inactivated in ma-
lignant ATL clones.
Following 3′ processing, the PIC needs to engage host
chromatin to catalyse strand transfer. Lentiviruses and
mousemammary tumour viruses are unique in usurping the
endogenous nuclear import machinery, whereas all other
retroviruses depend on nuclear envelope breakdown dur-
ing mitosis to bring the PIC into contact with chromatin
(45,46). By its association and dephosphorylation of co-
hesin, B′-PP2A was shown to play a role in metaphase to
anaphase progression (19) and could thus facilitate nuclear
import of the HTLV PIC.
B′-PP2A dephosphorylates transcription factors such as
p53, STAT1 and HDACs (47,33), of which cognate TFBs
were found enriched close to HTLV-1 integration sites in
a small but significant fraction of the infected cells (17).
Unlike the best characterized retroviral IN host factors,
LEDGF/p75 and Brd2–4, B′-PP2A does not directly as-
sociate with chromatin, but it can link the PIC to chro-
matin through any of these (and other yet unidentified)
binding partners/substrates. Many of these factors also co-
precipitated with HTLV-1 IN (Supplementary Table S3).
Morework is required to investigate the importance of these
associations.
HTLV-1 is a notoriously difficult virus to work with; cell-
to-cell transmission occurs through the virological synapse
(48), and cell-free transductions using HLTV-derived vec-
tors are ∼1000-fold less efficient than lentiviral transduc-
tions (49). Moreover, -retroviral INs associate with B′
of which there are at least five family members compris-
ing minimally 10 (splice/translational) isoforms (19). Al-
though it was shown that only the B′ and B′ isoforms
are nuclear in a cell cycle dependent manner (35,50), all five
B′ isoforms interact with centromeres/kinetochores during
prometaphase (51). Thus, if (one of) the roles of B′-PP2A is
to target the HTLV PIC to the site of integration, given the
partial functional redundancy of the different B′ isoforms
(52) and the fact that HTLV requires cells to go throughmi-
tosis to establish infection, any of these 10 isoforms could
be involved. Of importance, whereas knock-down of indi-
vidual B′ subunits does not adversely affect cell viability,
targeting multiple B′ subunits is detrimental for cell sur-
vival (26). As a consequence, simple shRNA mediated ap-
proaches might not reveal whether B′-PP2A is critical for
HTLV-1 infection and/or integration site selection. The use
of PP2A inhibitors is an attractive alternative, although no
distinction is made between B′ containing and other het-
erotrimeric PP2A holoenzymes using these chemical com-
pounds (18).
CONCLUSIONS
B′-PP2A is a functional -retroviral IN binding partner that
displays some key characteristics of a PIC targeting factor:
the interaction between B′-PP2A and IN is genus-specific,
both IN and B′-PP2A co-localize in the nucleus of the cell,
and B′ significantly stimulates concerted integration of -
retroviral INs. Current investigations are focussed on deter-
mining whether PP2A targets the HTLV-1 PIC to its site of
integration. It appears that HTLV INs when present in a 2-
fold molar excess do not influence the activity of B′-PP2A
on a phospho-Thr peptide. However, more work is needed
to verify whether certain PP2A substrate(s) are affected by
the association of B′-PP2A with this viral enzyme. Site di-
rected mutagenesis carried out in this work has identified
three highly conserved B′ residues critical for the interaction
with and stimulation of HTLV-1 and -2 IN activity. Further
characterization of the B′-PP2A : HTLV-1 IN interaction
interface is ongoing with the goal of identifying the HTLV-
1 IN residues involved in binding to B′. This information
can then be used to further identify the role(s) of PP2A in
-retroviral infection.
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